Clinical Trial Update: Stroke and MI in Users of Estrogen/Progestogen

View source ↗

Summary

This completed NHLBI trial updates findings on the risk of stroke and myocardial infarction in users of estrogen/progestin hormone therapy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiovascular Disease
• Coronary Artery Disease
• Myocardial Infarction
• Stroke

Drugs mentioned

• Estrogen/progestin therapy (Conjugated estrogens with medroxyprogesterone acetate)

Snippet

Sponsor: National Heart, Lung, and Blood Institute (NHLBI) | Conditions: Cardiovascular Diseases, Heart Diseases | Status: COMPLETED